The use of ex vivo-activated memory T cells (autolymphocyte therapy) in the treatment of metastatic renal cell carcinoma: final results from a randomized, controlled, multisite study.
S Graham, R K Babayan, D L Lamm, I Sawczuk, S D Ross, P T Lavin, M E Osband, R J Krane
Author Information
- S Graham: Department of Urology of Emory University School of Medicine, Atlanta, GA.
No abstract text available.
Adult
Aged
Aged, 80 and over
Carcinoma, Renal Cell
Cimetidine
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Immunologic Memory
Immunotherapy, Adoptive
Kidney Neoplasms
Lymphocyte Activation
Male
Middle Aged
Patient Compliance
Prospective Studies
Quality of Life
Remission Induction
Survival Rate
T-Lymphocytes
United States
